The pharmaceutical landscape for diabetes is evolving, and transdermal GLP-1 delivery systems represent a potential development. Unlike shots, this method offers a simpler way to deliver GLP-1 therapies. These https://geraldtrrm968305.widblog.com/95847192/glp-1-patches-a-novel-approach-to-glucose-control